Maria Florencia Sanchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria Florencia Sanchez has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Robert Tampé
Goethe University Frankfurt
3 shared publications - Alfredo Lorenzo
Instituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC-CONICET-Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publication - Annette Gabriele Beck‐Sickinger
Institute of Biochemistry Leipzig University Leipzig Germany
1 shared publication Carlos Leandro Freites
Instituto de Investigación Médica Mercedes y Martín Ferreyra, INIMEC-CONICET-Universidad Nacional de Córdoba, Friuli 2434, 5016 Córdoba, Argentina
1 shared publication- Elena Anahi Bignante
Departamento de Química Biológica Ranwel Caputto,Research Centre in Biological Chemistry of Córdoba,Córdoba,Argentina, Argentina
1 shared publication - Gonzalo Quassollo
Instituto de Investigación Médica Mercedes y Martín Ferreyra (INIMEC), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Córdoba 1 , Córdoba 5016 , Argentina
1 shared publication
Latest Publications
- 14 September 2022
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 48 (2) , 156-171
Ligand-independent receptor clustering modulates transmembrane signaling: a new paradigm
- 14 September 2022
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 48 (2) , 156-171
Ligand-independent receptor clustering modulates transmembrane signaling: a new paradigm
- Open Access
Dynamic in situ confinement triggers ligand-free neuropeptide receptor signaling
Membrane receptors are central to cell-cell communication. Receptor clustering at the plasma membrane modulates physiological responses, and mesoscale receptor organization is critical for downstream signaling. Spatially restricted cluster formation of the neuropeptide Y 2 hormone receptor (Y 2 R) was observed in vivo ; however, the relevance of this confinement is not fully understood. Here, we controlled Y 2 R clustering in situ by a chelator nanotool. Due to the multivalent interaction, we observed a dynamic exchange in the microscale confined regions. Fast Y 2 R enrichment in clustered areas triggered a ligand-independent downstream signaling determined by an increase in cytosolic calcium, cell spreading, and migration. We revealed that the cell response to ligand-induced activation was amplified when cells were pre-clustered by the nanotool. Ligand-independent signaling by clustering differed from ligand-induced activation in the binding of arrestin-3 as downstream effector, which was recruited to the confined regions only in the presence of the ligand. This approach enables in situ clustering of membrane receptors and raises the possibility to explore different modalities of receptor activation. Abstract Figure:
Open AccessDynamic in situ confinement triggers ligand-free neuropeptide receptor signaling
Membrane receptors are central to cell-cell communication. Receptor clustering at the plasma membrane modulates physiological responses, and mesoscale receptor organization is critical for downstream signaling. Spatially restricted cluster formation of the neuropeptide Y 2 hormone receptor (Y 2 R) was observed in vivo ; however, the relevance of this confinement is not fully understood. Here, we controlled Y 2 R clustering in situ by a chelator nanotool. Due to the multivalent interaction, we observed a dynamic exchange in the microscale confined regions. Fast Y 2 R enrichment in clustered areas triggered a ligand-independent downstream signaling determined by an increase in cytosolic calcium, cell spreading, and migration. We revealed that the cell response to ligand-induced activation was amplified when cells were pre-clustered by the nanotool. Ligand-independent signaling by clustering differed from ligand-induced activation in the binding of arrestin-3 as downstream effector, which was recruited to the confined regions only in the presence of the ligand. This approach enables in situ clustering of membrane receptors and raises the possibility to explore different modalities of receptor activation. Abstract Figure:
- 26 March 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6536) , 1334-+
Photoinduced receptor confinement drives ligand-independent GPCR signaling
Laser-controlled receptor clustering: A strategy that allows light-controlled local confinement of a heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptor may help to elucidate signal transduction mechanisms. Sánchez et al. developed just such an approach using a poly-L-lysine-graft-polyethylene glycol copolymer with a photoactivatable head. Laser light could locally activate a chelator that rapidly (within seconds) captured polyhistidine-tagged neuropeptide Y receptors. Such receptor confinement enhanced calcium signaling and increased spreading and cell motility in cultured human cells. The ability to control the location, size, and density of receptor clusters may help to elucidate receptor signaling mechanisms. Science , this issue p. eabb7657
- 26 March 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6536) , 1334-+
Photoinduced receptor confinement drives ligand-independent GPCR signaling
Laser-controlled receptor clustering: A strategy that allows light-controlled local confinement of a heterotrimeric guanine nucleotide–binding protein (G protein)–coupled receptor may help to elucidate signal transduction mechanisms. Sánchez et al. developed just such an approach using a poly-L-lysine-graft-polyethylene glycol copolymer with a photoactivatable head. Laser light could locally activate a chelator that rapidly (within seconds) captured polyhistidine-tagged neuropeptide Y receptors. Such receptor confinement enhanced calcium signaling and increased spreading and cell motility in cultured human cells. The ability to control the location, size, and density of receptor clusters may help to elucidate receptor signaling mechanisms. Science , this issue p. eabb7657
- Open Access
Aβ promotes amyloidogenic processing of APP through a Go/Gβγ signaling
Alzheimer’s disease (AD) is characterized by a cognitive impairment associated to amyloid beta (Aβ) aggregation and deposition in the brain. Aβ is generated by sequential cleavage of the amyloid precursor protein (APP) by β-site APP cleaving enzyme 1 (BACE1) and γ-secretase complex. The mechanisms that underlie exacerbated production of Aβ, favoring its deposition in the brain, is largely unknown. In vitro studies have shown that Aβ aggregates trigger enhanced production of Aβ by a yet non described mechanism. Here, we show that in different cell types, including human neurons derived from induced pluripotent stem cells (iPSC), oligomers and fibrils of Aβ enhance the convergence and interaction of APP and BACE1 in endosomal compartments. We demonstrated a key role of Aβ-APP/Go/Gβγ signaling on the amyloidogenic processing of APP. We show that APP mutants with impaired capacity to bind Aβ or to activate Go protein, are unable to exacerbate APP and BACE1 colocalization in the presence of Aβ. Moreover, pharmacological inhibition of Gβγ subunits signaling with gallein, abrogate Aβ-dependent interaction of APP and BACE1 in endosomes preventing β-processing of APP. Collectively, these findings uncover a feed-forward mechanism of amyloidogenesis that might contribute to Aβ pathology in early stages of AD and suggest that gallein might have clinical relevance.
Open AccessAβ promotes amyloidogenic processing of APP through a Go/Gβγ signaling
Alzheimer’s disease (AD) is characterized by a cognitive impairment associated to amyloid beta (Aβ) aggregation and deposition in the brain. Aβ is generated by sequential cleavage of the amyloid precursor protein (APP) by β-site APP cleaving enzyme 1 (BACE1) and γ-secretase complex. The mechanisms that underlie exacerbated production of Aβ, favoring its deposition in the brain, is largely unknown. In vitro studies have shown that Aβ aggregates trigger enhanced production of Aβ by a yet non described mechanism. Here, we show that in different cell types, including human neurons derived from induced pluripotent stem cells (iPSC), oligomers and fibrils of Aβ enhance the convergence and interaction of APP and BACE1 in endosomal compartments. We demonstrated a key role of Aβ-APP/Go/Gβγ signaling on the amyloidogenic processing of APP. We show that APP mutants with impaired capacity to bind Aβ or to activate Go protein, are unable to exacerbate APP and BACE1 colocalization in the presence of Aβ. Moreover, pharmacological inhibition of Gβγ subunits signaling with gallein, abrogate Aβ-dependent interaction of APP and BACE1 in endosomes preventing β-processing of APP. Collectively, these findings uncover a feed-forward mechanism of amyloidogenesis that might contribute to Aβ pathology in early stages of AD and suggest that gallein might have clinical relevance.